Clinical trial

Evaluation of Skin Tests in Biotherapy Allergies

NCT06971848

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-06-17

PhaseNA

Study timeline

Study start (actual)2026-06-17Date precision: day

Registry last updated2026-06-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neckunresolved

Melanoma Neoplasmsunresolved

Small Cell Bronchial Carcinomasunresolved

Bronchial Carcinomaunresolved

Pleural Mesotheliomaunresolved

Hodgkin's Lymphomaunresolved

Chronic Lymphocytic Leukemiaunresolved

Follicular Lymphomaunresolved

Myelomaunresolved

AL Amyloidosisunresolved

Hepatocarcinomaunresolved

Colorectal Cancerunresolved

Esophageal Squamous Cell Carcinomaunresolved

Heart Cancerunresolved

Cholangiocarcinomaunresolved

Colorectal Adenocarcinomaunresolved

Interventions

Drug skin tests (investigating hypersensitivity to a biotherapy)OTHER

Sponsors & collaborators

University Hospital, Angerslead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06971848 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.